Table 6.
Demographic characteristics of children who contributed clindamycin PK data for the analysis
| Variable | Median (Range) or N (%) | ||
|---|---|---|---|
| 1 month-2 years | 2–6 years | 6–18 years | |
| Number of subjects | 10 | 6 | 13 |
| Gestational age (weeks) | 37 (33–40)a | - | - |
| Postmenstrual age (weeks) | 67 (51–78)b | - | - |
| Postnatal age (years) | 0.64 (0.27–1.45) | 4 (3.56–5.93) | 9.18 (6.06–15.98) |
| Body weight (kg) | 8.45 (5.5–11.7) | 16.3 (14.7–21.1) | 41.2 (16.9–72.7) |
| Female | 4 (40) | 2 (33) | 7 (54) |
| Race | |||
| White | 5 (50) | 5 (83) | 11 (84) |
| Black or African American | 2 (20) | 1 (17) | 1 (8) |
| Asian | 2 (20) | 0 | 0 |
| More than one race | 1 (10) | 0 | 0 |
| Other or not reported | 0 | 0 | 1 (8) |
PK, pharmacokinetic
a
Gestational age reported for subjects with postnatal age <1 year (N=7 subjects).
b
Postmenstrual age computed for subjects with postnatal age <1 year as the sum of gestational and postnatal age (N=7 subjects).